Continuous Positive Airway Pressure Treatment and Depression in Adults with Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea. A Secondary Analysis of the RICCADSA Trial.
Mehmet Baran BalcanErik ThunströmPatrick J StrolloYüksel PekerPublished in: Annals of the American Thoracic Society (2020)
Among adults with depression, nonsleepy OSA, and CAD, 3 months of CPAP treatment improved depression scores. The improvement in mood persisted up to 12 months. An on-treatment adjusted analysis confirmed these findings. Clinical trial registered with www.clinicaltrials.gov (NCT00519597).
Keyphrases
- obstructive sleep apnea
- positive airway pressure
- coronary artery disease
- clinical trial
- sleep quality
- sleep apnea
- study protocol
- heart failure
- cardiovascular disease
- phase ii
- physical activity
- percutaneous coronary intervention
- left ventricular
- acute coronary syndrome
- replacement therapy
- transcatheter aortic valve replacement